Načítá se...
Transapical transcatheter aortic valve implantation for predominant aortic regurgitation with a self-expandable valve
BACKGROUND: Transcatheter aortic valve implantation (TAVI) has become the gold standard for high-risk severe aortic stenosis. However, the experience of treating aortic regurgitation (AR) with this technology is still limited. Previously, we have demonstrated excellent 1-year outcomes of transapical...
Uloženo v:
| Vydáno v: | J Thorac Dis |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7139073/ https://ncbi.nlm.nih.gov/pubmed/32274119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2020.01.04 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|